Plain-English translation of NCT04306458 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether robot-assisted minimally invasive esophagectomy (a surgery where a surgeon uses a robot to help remove the esophagus) works better than conventional minimally invasive esophagectomy for people with esophageal adenocarcinoma. The main question is whether the robotic approach allows surgeons to remove more lymph nodes — which are important to check for cancer spread — and whether this leads to better outcomes for patients.
Current minimally invasive surgery for esophageal cancer is effective, but surgeons want to know if using robotic assistance can help them remove lymph nodes more thoroughly and improve survival rates. This trial will help doctors understand which surgical approach is best for patients with this type of cancer.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either robot-assisted minimally invasive esophagectomy or conventional minimally invasive esophagectomy. Both are surgical procedures where your esophagus is removed through small incisions rather than one large cut. Your surgical team will monitor you closely before and after surgery, and researchers will track your recovery, how many lymph nodes were removed, and your long-term health outcomes to compare the two surgical approaches.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Germany